miR‐15a and miR‐16‐1 down‐regulation in pituitary adenomas

Micro RNAs (miRs) are small noncoding RNAs, functioning as antisense regulators of other RNAs. miR‐15a and miR‐16‐1 genes are located at chromosome 13q14, a region which is frequently deleted in pituitary tumors. An inverse correlation has been shown in B cell chronic lymphocytic leukemia (B‐CLL) between miR‐15a and miR‐16‐1 expression and the expression levels of arginyl‐tRNA synthetase (RARS), an enzyme which associates with the cofactor p43 in the aminoacyl‐tRNA synthetase complex. When secreted, p43 regulates local inflammatory response and macrophage chemotaxis, and seems to have anti‐neoplastic properties in mice. We explored miR‐15a and miR‐16‐1 expression in 10 GH‐secreting and in 10 PRL‐secreting pituitary macroadenomas by Northern blot, and investigated the possible correlation with in vivo and in vitro characteristics. We found that miR‐15a and miR‐16‐1 are expressed at lower levels in pituitary adenomas as compared to normal pituitary tissue. Moreover, their expression inversely correlates with tumor diameter and with RARS expression (P < 0.05), but directly correlates with p43 secretion (P < 0.02). Therefore, miR15 and miR16 down‐regulation in pituitary adenomas correlates with a greater tumor diameter and a lower p43 secretion, suggesting that these genes may, at least in part, influence tumor growth. © 2005 Wiley‐Liss, Inc.

[1]  M. Culler,et al.  Somatostatin receptor subtype 1 selective activation in human growth hormone (GH)- and prolactin (PRL)-secreting pituitary adenomas: effects on cell viability, GH, and PRL secretion. , 2003, The Journal of clinical endocrinology and metabolism.

[2]  P. Vandenabeele,et al.  The EMAPII Cytokine Is Released from the Mammalian Multisynthetase Complex after Cleavage of Its p43/proEMAPII Component* , 2001, The Journal of Biological Chemistry.

[3]  A. Paetau,et al.  Gain of chromosome 3 and loss of 13q are frequent alterations in pituitary adenomas. , 2001, Cancer genetics and cytogenetics.

[4]  Sunghoon Kim,et al.  A Cofactor of tRNA Synthetase, p43, Is Secreted to Up-regulate Proinflammatory Genes* , 2001, The Journal of Biological Chemistry.

[5]  C. Croce,et al.  An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[6]  C. Croce,et al.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Rutka,et al.  Molecular Pathogenesis of Pituitary Adenomas: A Review , 1999, Acta Neurochirurgica.

[8]  R. Thakker,et al.  Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. , 1997, The Journal of clinical endocrinology and metabolism.

[9]  K Autio,et al.  DNA copy number losses in human neoplasms. , 1999, The American journal of pathology.

[10]  Z. Qian,et al.  Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness. , 2004, The Journal of clinical endocrinology and metabolism.

[11]  B. Scheithauer,et al.  Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. , 1995, Cancer research.

[12]  M. Siatecka,et al.  Macromolecular assemblage of aminoacyl-tRNA synthetases: identification of protein-protein interactions and characterization of a core protein. , 1999, Journal of molecular biology.

[13]  M. Deutscher,et al.  A basic NH2-terminal extension of rat liver arginyl-tRNA synthetase required for its association with high molecular weight complexes. , 1987, The Journal of biological chemistry.

[14]  Jun Li,et al.  Endothelial-Monocyte Activating Polypeptide Ii, a Novel Antitumor Cytokine That Suppresses Primary and Metastatic Tumor Growth and Induces Apoptosis in Growing Endothelial Cells , 1999, The Journal of experimental medicine.

[15]  C. Croce,et al.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  V. Ambros.  microRNAs Tiny Regulators with Great Potential , 2001, Cell.

[17]  T. Tuschl,et al.  Identification of Novel Genes Coding for Small Expressed RNAs , 2001, Science.

[18]  T. Tuschl,et al.  Identification of Tissue-Specific MicroRNAs from Mouse , 2002, Current Biology.

[19]  S. Libutti,et al.  In vivo sensitivity of human melanoma to tumor necrosis factor (TNF)-alpha is determined by tumor production of the novel cytokine endothelial-monocyte activating polypeptide II (EMAPII). , 1999, Cancer research.

[20]  J. Haidar,et al.  Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors. , 2001, The Journal of clinical endocrinology and metabolism.

[21]  M. Mirande.  Aminoacyl-tRNA synthetase family from prokaryotes and eukaryotes: structural domains and their implications. , 1991, Progress in nucleic acid research and molecular biology.

[22]  M. Mirande,et al.  The p43 Component of the Mammalian Multi-synthetase Complex Is Likely To Be the Precursor of the Endothelial Monocyte-activating Polypeptide II Cytokine* , 1997, The Journal of Biological Chemistry.

[23]  C. Croce,et al.  MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Mann,et al.  miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. , 2002, Genes & development.

[25]  D. Söll,et al.  Aminoacyl-tRNA synthesis. , 2000, Annual review of biochemistry.